4. Segment Information and Concentrations

6 Months Ended

Dec. 31, 2012

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments:  the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (ABenchtop Laboratory Equipment@), the manufacture and marketing of custom-made catalyst research instruments  for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (ACatalyst Research Instruments@) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors (“Bioprocessing Systems”).

Segment information is reported as follows (foreign sales are principally to customers in Europe and Asia):

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2012
Net Sales	$	1,164,900	$	664,900		$	47,100		$	-		$	1,876,900
Foreign Sales		747,900		279,800			-			-			1,027,700
Profit (Loss)		157,200		68,200			(30,900	)		-			194,500
Assets		2,485,700		1,695,400			963,100			915,800			6,060,000
Long-Lived Asset Expenditures		7,100		700			-			-			7,800
Depreciation and Amortization		11,500		9,200			24,000			-			44,700
	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2011
Net Sales	$	1,108,500	$	89,100		$	-		$	-		$	1,197,600
Foreign Sales		755,100		8,400			-			-			763,500
Profit (Loss)		100,200		(117,800	)		(32,300	)		(33,600	)		(83,500	)
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		4,500		2,800			876,000			-			883,300
Depreciation and Amortization		12,300		27,800			12,000			-			52,100

Approximately 73% and 63% of net sales of benchtop laboratory equipment (46% and 59% of total net sales) for the three month periods ended December 31, 2012 and 2011, respectively, were derived from the Company’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Two customers accounted in the aggregate for approximately 24% and 26% of the net sales of the Benchtop Laboratory Equipment Operations and 15% and 24% of total net sales for the three months ended December 31, 2012, and 2011, respectively.  Sales of catalyst research instruments generally comprise a few very large orders averaging at least $100,000 per order to a limited number of customers, who differ from order to order.  Sales to four customers and one customer represented approximately 95% and 73% of the Catalyst Research Instrument Operations’ net sales, respectively, and 34% and 25% of total net sales for the three months ended December 31, 2012 and 2011, respectively.

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2012
Net Sales	$	2,229,700	$	949,200		$	49,700		$	-		$	3,228,600
Foreign Sales		1,369,600		519,000			-			-			1,888,600
Profit (Loss)		274,800		(66,100	)		(105,900	)		-			102,800
Assets		2,485,700		1,695,400			963,100			915,800			6,060,000
Long-Lived Asset Expenditures		9,200		18,100			-			-			27,300
Depreciation and Amortization		22,600		18,500			47,900			-			89,000
	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2011
Net Sales	$	2,183,600	$	554,900		$	-		$	-		$	2,738,500
Foreign Sales		1,363,700		121,100			-			-			1,484,800
Profit (Loss)		260,600		(176,400	)		(32,300	)		(58,200	)		(6,300)
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		14,000		49,500			876,000			-			939,500
Depreciation and Amortization		24,300		63,000			12,000			-			99,300

Approximately 68% and 63% of net sales of benchtop laboratory equipment (47% and 50% of total net sales) for the six month periods ended December 31, 2012 and 2011, respectively, were derived from the segment’s main product, the Vortex- Genie 2® mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted in the aggregate for approximately 23% of the segment=s net sales for each of the two comparative periods and  16% and 19%, respectively, of total net sales for the six month periods ended December 31, 2012 and 2011.

Sales of catalyst research instruments to four different customers in each of the six month periods, accounted for approximately 67% and 88% of the segment=s net sales and 20% and 18% of total net sales for the six month period ended December 31, 2012 and 2011, respectively.